Promising Alzheimer's drug may also improve memory in down syndrome and normal aging - EurekAlert

New research is breaking ground in repurposing an FDA-approved drug as a potential treatment in Down syndrome and normal aging. The results reported in the journal Neurobiology of Disease suggest that GM-CSF may improve cognitive function in people with Down…

A new study shows that a potential treatment for Alzheimer’s disease may also improve cognitive function in people with Down syndrome. The drug sargramostim (GM-CSF, which stands for granulocyte-mac… [+4615 chars]

full article...